Modulation of Tumor-Associated Macrophages to Overcome Immune Suppression in the Hepatocellular Carcinoma Microenvironment
Cancers · 29.12.2024 · 17 (1) · 66
DOI: 10.3390/cancers17010066 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 29.12.2024. Verfasst von Mahmoud Singer und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiological Sciences, School of Medicine, University of California, Irvine, CA 92617, USA. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 122 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is a major global health issue characterized by poor prognosis and complex tumor biology. One of the critical components of the HCC tumor microenvironment (TME) is tumor-associated macrophages (TAMs), which play a pivotal role in modulating tumor growth, immune evasion, and metastasis. Macrophages are divided into two major subtypes: pro-inflammatory M1 and anti-inflammatory M2, both of which may exist in TME with altered function and proportion. The anti-inflammatory M2 macrophages are further subdivided into four distinct immune suppressive subsets. TAMs are generally counted as M2-like macrophages with altered immune suppressive functions that exert a significant influence on both cancer progression and the ability of tumors to escape immune surveillance. Their involvement in modulating immune responses via different mechanisms at the local and systemic levels has made them a key target for therapeutic interventions seeking to enhance treatment outcomes. How TAMs’ depletion influences immune responses in cancer is the primary interest in cancer immunotherapies. The purpose of this review is to delve into the recent progress made in TAM-targeting therapies. We will explore the current theories, benefits, and challenges associated with TAMs’ depletion or inhibition. The manuscript concludes with future directions and potential implications for clinical practice.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiological Sciences, School of Medicine, University of California, Irvine, CA 92617, USA.
- Department of Medicine, Chao Family Comprehensive Cancer Center, University of California, Irvine, CA 92867, USA.
- Department of Surgery, University of California Irvine, Orange, CA 92697, USA.
ORCID-Profile: Mahmoud Singer, Farshid Dayyani, April Choi, David Imagawa, Nadine Abi-Jaoudeh
Förderung
- NCI NIH HHS
Zitieren
APA
Singer, M., Zhang, Z., Dayyani, F., Zhang, Z., Yaghmai, V., Choi, A., Valerin, J., Imagawa, D., & Abi-Jaoudeh, N. (2024). Modulation of Tumor-Associated Macrophages to Overcome Immune Suppression in the Hepatocellular Carcinoma Microenvironment. Cancers, 17(1), 66. https://doi.org/10.3390/cancers17010066
Vancouver
Singer M, Zhang Z, Dayyani F, Zhang Z, Yaghmai V, Choi A, et al. Modulation of Tumor-Associated Macrophages to Overcome Immune Suppression in the Hepatocellular Carcinoma Microenvironment. Cancers. 2024;17(1):66. doi:10.3390/cancers17010066
BibTeX
@article{Singer2024,
author = {Singer, Mahmoud and Zhang, Zhuoli and Dayyani, Farshid and Zhang, Zigeng and Yaghmai, Vahid and Choi, April and Valerin, Jennifer and Imagawa, David and Abi-Jaoudeh, Nadine},
title = {Modulation of Tumor-Associated Macrophages to Overcome Immune Suppression in the Hepatocellular Carcinoma Microenvironment},
journal = {Cancers},
year = {2024},
volume = {17},
number = {1},
pages = {66},
doi = {10.3390/cancers17010066}
}
EUVIMED